IMCB (Gemabank) is a medical company and market leader among stem cell banks in Russia. It offers services in collection, isolation, cryopreservation and storage of PC ICs. It occupies about 44% of the Russian market at the end of 2018 by the number of samples in storage.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
IMCB news
22.09.2025
Shareholders of IMCB approved dividends for 6 months 2025 in the amount of ₽5 per ordinary share. Last day of purchase of securities to receive dividends is September 26, 2025. Dividend yield may amount to 4.08%.
Source: 
e-disclosure.ru
e-disclosure.ru
14.08.2025
Board of Directors of IMCB recommended that dividends be paid for 6 months 2025 in the amount of ₽5 per ordinary share. The last day of the purchase of securities to receive dividends is September 26, 2025. Dividend yield may amount to 4.07%.
Source: disclosure.skrin.ru
07.08.2025
MMCB's RAS net profit for 6 months of 2025 amounted to ₽80.01 million, which is 0.1% lower than ₽80.09 million in the previous year. Revenue increased by 11.6% to ₽183.7 million from ₽164.6 million a year earlier.
Source: e-disclosure.ru
e-disclosure.ru
06.06.2025
Shareholders of IMCB approved dividends for 2024 in the amount of ₽2.4 per ordinary share. The last day of purchase of securities to receive dividends is June 13, 2025. Dividend yield may amount to 1.99%.
Source: disclosure.skrin.ru
General information
| Company name | IMCB |
|---|---|
| Tags | #biotechnology, #innovations of the russia, #stem cells |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | gorod Moskva |
| Mailing address | 119333, g. Moskva, ul. Gubkina, d. 3, korp. 1, etazh 1, pom. 1, komn. 24 |
| CEO | Prihodko Aleksandr Viktorovich |
| Phone | +7(495) 646-80-76 |
| Website | invest.gemabank.ru |
| Information disclosure | e-disclosure.ru |
English (US) 